{"id":"https://openalex.org/W3036137756","doi":"https://doi.org/10.1158/0008-5472.can-20-0056","title":"Pharmacokinetic Profiles Determine Optimal Combination Treatment Schedules in Computational Models of Drug Resistance","display_name":"Pharmacokinetic Profiles Determine Optimal Combination Treatment Schedules in Computational Models of Drug Resistance","publication_year":2020,"publication_date":"2020-06-19","ids":{"openalex":"https://openalex.org/W3036137756","doi":"https://doi.org/10.1158/0008-5472.can-20-0056","mag":"3036137756","pmid":"https://pubmed.ncbi.nlm.nih.gov/32561532","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7442591"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.can-20-0056","doi":"https://doi.org/10.1158/0008-5472.can-20-0056","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-20-0056","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7442591","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013931444","display_name":"Itziar Irurzun\u2010Arana","orcid":"https://orcid.org/0000-0001-6084-4481","observed_orcids":["https://orcid.org/0000-0001-6084-4481"]},"institutions":[{"id":"https://openalex.org/I4210112085","display_name":"Navarre Institute of Health Research","ror":"https://ror.org/023d5h353","country_code":"ES","type":"education","lineage":["https://openalex.org/I4210112085"]},{"id":"https://openalex.org/I88155538","display_name":"Universidad de Navarra","ror":"https://ror.org/02rxc7m23","country_code":"ES","type":"education","lineage":["https://openalex.org/I88155538"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Itziar Irurzun-Arana","raw_affiliation_strings":["1Pharmacometrics and Systems Pharmacology, Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain","2Navarra Institute for Health Research (IdisNA), University of Navarra, Pamplona, Spain"],"raw_orcid":"https://orcid.org/0000-0001-6084-4481","affiliations":[{"raw_affiliation_string":"1Pharmacometrics and Systems Pharmacology, Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain","institution_ids":["https://openalex.org/I88155538"]},{"raw_affiliation_string":"2Navarra Institute for Health Research (IdisNA), University of Navarra, Pamplona, Spain","institution_ids":["https://openalex.org/I4210112085","https://openalex.org/I88155538"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051162687","display_name":"Thomas O. McDonald","orcid":"https://orcid.org/0000-0002-5272-0187","observed_orcids":["https://orcid.org/0000-0002-5272-0187"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas O. McDonald","raw_affiliation_strings":["3Department of Data Sciences, Dana-Farber Cancer Institute, and Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts","4Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts","5Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Data Sciences, Dana-Farber Cancer Institute, and Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"raw_affiliation_string":"4Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"5Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087528420","display_name":"I\u00f1aki F. Troc\u00f3niz","orcid":"https://orcid.org/0000-0003-3700-8658","observed_orcids":["https://orcid.org/0000-0003-3700-8658"]},"institutions":[{"id":"https://openalex.org/I4210112085","display_name":"Navarre Institute of Health Research","ror":"https://ror.org/023d5h353","country_code":"ES","type":"education","lineage":["https://openalex.org/I4210112085"]},{"id":"https://openalex.org/I88155538","display_name":"Universidad de Navarra","ror":"https://ror.org/02rxc7m23","country_code":"ES","type":"education","lineage":["https://openalex.org/I88155538"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"I\u00f1aki F. Troc\u00f3niz","raw_affiliation_strings":["1Pharmacometrics and Systems Pharmacology, Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain","2Navarra Institute for Health Research (IdisNA), University of Navarra, Pamplona, Spain"],"raw_orcid":"https://orcid.org/0000-0003-3700-8658","affiliations":[{"raw_affiliation_string":"1Pharmacometrics and Systems Pharmacology, Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain","institution_ids":["https://openalex.org/I88155538"]},{"raw_affiliation_string":"2Navarra Institute for Health Research (IdisNA), University of Navarra, Pamplona, Spain","institution_ids":["https://openalex.org/I4210112085","https://openalex.org/I88155538"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091861581","display_name":"Franziska Michor A","orcid":"https://orcid.org/0000-0003-4869-8842","observed_orcids":["https://orcid.org/0000-0003-4869-8842","https://orcid.org/0009-0003-8552-7767"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Franziska Michor","raw_affiliation_strings":["3Department of Data Sciences, Dana-Farber Cancer Institute, and Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts","4Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts","5Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, Massachusetts","6The Broad Institute of Harvard and MIT, Cambridge, Massachusetts","7The Ludwig Center at Harvard, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Data Sciences, Dana-Farber Cancer Institute, and Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"raw_affiliation_string":"4Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"5Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"6The Broad Institute of Harvard and MIT, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I107606265","https://openalex.org/I63966007"]},{"raw_affiliation_string":"7The Ludwig Center at Harvard, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5091861581"],"corresponding_institution_ids":["https://openalex.org/I107606265","https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579","https://openalex.org/I63966007"],"apc_list":null,"apc_paid":null,"fwci":0.3575,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.71935573,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"80","issue":"16","first_page":"3372","last_page":"3382"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11829","display_name":"Mathematical Biology Tumor Growth","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2611","display_name":"Modeling and Simulation"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11829","display_name":"Mathematical Biology Tumor Growth","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2611","display_name":"Modeling and Simulation"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6510000228881836},{"id":"https://openalex.org/keywords/treatment-schedule-optimization","display_name":"treatment schedule optimization","score":0.6470000147819519},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7720000147819519},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.6570000052452087},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.8360000252723694},{"id":"https://openalex.org/keywords/tumor-growth-modeling","display_name":"tumor growth modeling","score":0.6570000052452087},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9929999709129333},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":0.9200000166893005},{"id":"https://openalex.org/keywords/optimal-dosing","display_name":"optimal dosing","score":0.6150000095367432}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8269168138504028},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5326368808746338},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.5119606256484985},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3962002694606781},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2764066457748413}],"mesh":[{"descriptor_ui":"D000069347","descriptor_name":"Erlotinib Hydrochloride","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000069347","descriptor_name":"Erlotinib Hydrochloride","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D012984","descriptor_name":"Software","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D016923","descriptor_name":"Cell Death","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1158/0008-5472.can-20-0056","doi":"https://doi.org/10.1158/0008-5472.can-20-0056","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-20-0056","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},{"id":"pmid:32561532","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32561532","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7442591","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7442591","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Cancer Res","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:7442591","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7442591","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Cancer Res","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2947589114","display_name":"Evolution and Treatment Response of Brain, Breast, and Hematologic Malignancies","funder_award_id":"U54CA193461","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W58756698","https://openalex.org/W124218942","https://openalex.org/W850470413","https://openalex.org/W1518009784","https://openalex.org/W1523572153","https://openalex.org/W1832539213","https://openalex.org/W1868962904","https://openalex.org/W1917533840","https://openalex.org/W1967304777","https://openalex.org/W1987191607","https://openalex.org/W1988414899","https://openalex.org/W1990013637","https://openalex.org/W2002069093","https://openalex.org/W2020299413","https://openalex.org/W2023560061","https://openalex.org/W2051990692","https://openalex.org/W2060254075","https://openalex.org/W2066330900","https://openalex.org/W2078532650","https://openalex.org/W2080669049","https://openalex.org/W2081886885","https://openalex.org/W2083573017","https://openalex.org/W2090615329","https://openalex.org/W2098560585","https://openalex.org/W2119160928","https://openalex.org/W2123431502","https://openalex.org/W2139236349","https://openalex.org/W2141635226","https://openalex.org/W2145980885","https://openalex.org/W2150550712","https://openalex.org/W2153938747","https://openalex.org/W2155582899","https://openalex.org/W2212640525","https://openalex.org/W2272802268","https://openalex.org/W2274550965","https://openalex.org/W2335854816","https://openalex.org/W2521448810","https://openalex.org/W2533097314","https://openalex.org/W2586629973","https://openalex.org/W2618035748","https://openalex.org/W2767281692","https://openalex.org/W2768977980","https://openalex.org/W2776883406","https://openalex.org/W2889213939","https://openalex.org/W2890622637","https://openalex.org/W2936652663","https://openalex.org/W4235035462","https://openalex.org/W4237377395","https://openalex.org/W7064220029"],"related_works":["https://openalex.org/W7111432575","https://openalex.org/W2564306535","https://openalex.org/W2566956777","https://openalex.org/W2013799896","https://openalex.org/W2049977830","https://openalex.org/W7133332914","https://openalex.org/W2413382302","https://openalex.org/W3016884253","https://openalex.org/W2053650904","https://openalex.org/W2020676762"],"abstract_inverted_index":{"Abstract":[0],"Identification":[1],"of":[2,22,32,41,48,96,99,126,133,140,144,159],"optimal":[3],"schedules":[4,36,92],"for":[5,67,174,189],"combination":[6,68,176,190],"drug":[7,18,50,103],"administration":[8],"relies":[9],"on":[10,38,54,93],"accurately":[11],"estimating":[12],"the":[13,39,94,97,157],"correct":[14],"pharmacokinetics,":[15],"pharmacodynamics,":[16],"and":[17,46,51,64,75,105,139,166,186,197],"interaction":[19,77,199],"effects.":[20],"Misspecification":[21],"pharmacokinetics":[23],"can":[24,86,108,167],"lead":[25],"to":[26,35,89,120,170],"wrongly":[27],"predicted":[28],"timing":[29],"or":[30,114],"order":[31],"treatments,":[33],"leading":[34],"recommended":[37],"basis":[40,95],"incorrect":[42],"assumptions":[43],"about":[44],"absorption":[45],"elimination":[47],"a":[49,60,182],"its":[52],"effect":[53],"tumor":[55],"growth.":[56],"Here,":[57],"we":[58],"developed":[59],"computational":[61,183],"modeling":[62,184],"platform":[63,185],"software":[65,85,187],"package":[66,162,188],"treatment":[69,127,141,191],"strategies":[70,192],"with":[71,128,142,193],"flexible":[72,194],"pharmacokinetic":[73,106,195],"profiles":[74,196],"multidrug":[76,198],"curves":[78,107,200],"that":[79,201],"are":[80,202],"estimated":[81,110,203],"from":[82,111,204],"data.":[83,205],"The":[84],"be":[87,109,168],"used":[88,169],"compare":[90],"prespecified":[91],"number":[98],"resistant":[100],"cells":[101,138],"where":[102],"interactions":[104],"user-provided":[112],"data":[113,125],"models.":[115],"We":[116],"applied":[117],"our":[118],"approach":[119,152],"publicly":[121,154],"available":[122,155],"in":[123,156],"vitro":[124],"different":[129],"tyrosine":[130],"kinase":[131],"inhibitors":[132],"BT-20":[134],"triple-negative":[135],"breast":[136],"cancer":[137,149],"erlotinib":[143],"PC-9":[145],"non\u2013small":[146],"cell":[147],"lung":[148],"cells.":[150],"Our":[151],"is":[153],"form":[158],"an":[160],"R":[161],"called":[163],"ACESO":[164],"(https://github.com/Michorlab/aceso)":[165],"investigate":[171],"optimum":[172],"dosing":[173],"any":[175],"treatment.":[177],"Significance:":[178],"These":[179],"findings":[180],"introduce":[181]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2020-06-25T00:00:00"}